Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Buys 10,000 SharesTicker Report • about 2 months ago
Rezolute, Inc. (NASDAQ:RZLT Get Free Report) insider Brian Kenneth Roberts acquired 10,000 shares of the stock in a transaction on Thursday, March 14th. The shares were purchased at an...
Share to Feed
Rezolute (NASDAQ:RZLT Get Free Report) and SCYNEXIS (NASDAQ:SCYX Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two...
Rezolute, Inc. (NASDAQ:RZLT Get Free Report) CFO Daron Evans purchased 50,000 shares of the stock in a transaction on Friday, March 8th. The shares were purchased at an average cost of $1.93...
Rezolute (NASDAQ:RZLT Get Free Report)s stock had its buy rating reaffirmed by HC Wainwright in a report released on Thursday, Benzinga reports. They presently have a...
Rezolute, Inc. (NASDAQ:RZLT Get Free Report) CFO Daron Evans purchased 50,000 shares of the companys stock in a transaction that occurred on Friday, March 8th. The shares were...
Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor over-activation (tumor hyperinsulinism)
Effects of RZ358 on Ligand-Induced...
HC Wainwright reaffirmed their buy rating on shares of Rezolute (NASDAQ:RZLT Free Report) in a report released on Wednesday, Benzinga reports. HC Wainwright currently has a $14.00 price...
Rezolute (NASDAQ:RZLT Get Free Report)s stock had its buy rating restated by HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $14.00...
Key Insights Rezolute's estimated fair value is US$0.87 based on 2 Stage Free Cash Flow to Equity Rezolute's US$1.14...
Phase 3 clinical study of RZ358 underway in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Benefit shown in individual patient cases with RZ358 for...